Botulinum toxin A injections in children: Technique and dosing issues

American Journal of Physical Medicine and Rehabilitation

Volumn 83, Issue 10 SUPPL., 2004, Pages

  Kinnett, Douglas ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Botulinum Toxin; Children; Intramuscular Injections; Literature Review

Indexed keywords

BOTULINUM TOXIN A;

ANXIETY; BODY WEIGHT; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; DILUTION; DOSE CALCULATION; ELECTROMYOGRAPHY; ELECTROSTIMULATION; HUMAN; INJECTION SITE; MEDICAL INFORMATION; MUSCLE; SCIENTIFIC LITERATURE; SEDATION; SIDE EFFECT; SPASTICITY; TECHNIQUE; ULTRASOUND;

BOTULINUM TOXIN TYPE A; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, INTRAMUSCULAR; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS;

EID: 4644284978     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PHM.0000141131.66648.E9     Document Type: Conference Paper

References (28)

1. Cosgrove AP, Corry IS, Graham HK: Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994;36:386-96
2. Koman LA, Mooney JF III, Smith B, et al: Management of cerebral palsy with botulinum-A toxin: Preliminary investigation. J Pediatr Orthop 1993;13:489-95
3. Russman BS, Tilton A, Gormley ME Jr: Cerebral palsy: A rational approach to a treatment protocol and the role of botulinum toxin in treatment. Muscle Nerve Suppl 1997;6:S181-93
4. Graham HK, Aoki KR, Autti-Ramo I, et al: Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000;11: 67-79
5. Bakheit AM: Botulinum toxin in the management of childhood muscle spasticity: Comparison of clinical practice of 17 treatment centres. Eur J Neurol 2003;10:415-9
6. Koman LA, Paterson Smith B, Balkrishnan R: Spasticity associated with cerebral palsy in children: Guidelines for the use of botulinum A toxin. Paediatr Drugs 2003;5:11-23
7. Koman LA, Mooney JF III, Smith BP, et al: Management of spasticity in cerebral palsy with botulinum-A toxin: Report of a preliminary, randomized, double-blind trial. J Pediatr Orthop 1994;14: 299-303
8. Chutorian AM, Root L: Management of spasticity in children with botulinum-A toxin. Intl Pediatr 1994;9(suppl 4):35-43
9. Calderon-Gonzalez R, Calderon-Sepulveda R, Rincon-Reyes M, et al: Botulinum toxin A in management of cerebral palsy. Pediatr Neurol 1994;10:284-8
10. Corry IS, Cosgrove AP, Duffy CM, et al: Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: A randomised prospective trial. J Pediatr Orthop 1998;18(3):304-11
11. Sutherland DH, Kaufman KR, Wyatt MP, et al: Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture 1999;10:1-9
12. Molenaers G, Desloovere K, Eyssen M, et al: Botulinum toxin type A treatment of cerebral palsy: an integrated approach. Eur J Neurol 1999;6(suppl 4): 511-7
13. Eames NW, Baker R, Hill N, et al: The effect of botulinum toxin A on gastrocnemius length: Magnitude and duration of response. Dev Med Child Neurol 1999;41: 226-32
14. Delgado MR, Combs M: Retrospective review of dose and safety of BOTOX injections in children with cerebral palsy. Mov Disord 2000;15(suppl 2):9-10
15. Feblings D, Rang M, Glazier J, et al: An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatric 2000;137:331-7
16. Koman LA, Mooney JF III, Smith BP, et al: Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: A randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop 2000;20:108-15
17. Boyd RN, Pliatsios V, Starr R, et al: Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy. Dev Med Child Neurol 2000;42:32-41
18. Gormley ME, Gaebler-Spira D, Delgado MR: Use of botulinum toxin type A in pediatric patients with cerebral palsy: A three-center retrospective chart review. J Child Neurol 2001;16:113-8
19. Autti-Ramo I, Larsen A, Taimo A, et al: Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: Clinical implications. Eur J Neurol 2001;8(suppl 5):136-44
20. Boyd RN, Dobson F, Parrott J, et al: The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: A randomized controlled trial. Eur J Neurol 2001;8(suppl 5): 109-19
21. Reddihough DS, King JA, Coleman GJ, et al: Functional outcome of botulinum toxin A injections to the lower limbs in cerebral palsy. Dev Med Child Neurol 2002;44:820-7
22. Flett PJ: Rehabilitation of spasticity and related problems in childhood cerebral palsy. J Paediatr Child Health 2003; 39:6-14
23. Hurvitz EA, Conti GE, Brown SH: Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection. Arch Phys Med Rehabil 2003;84:444-54
24. Scott AB, Suzuki D: Systemic toxicity of botulinum toxin by intramuscular injection in the monkey. Mov Disord 1988; 3:333-5
25. Arezzo JC, Litwak MS, Caputo FA, et al: Spread of paralysis to nearby and distant noninjected muscles in a monkey hand model: Comparison of BoNT-B and BoNT-A, in Brin ME, Hallett M, Jankovic J (eds): Scientic and Therapeutic Aspects of Botulinum Toxin. Philadelphia, Lippincott, Williams, and Wilkens, 2002, pp 123-33
26. Kim HS, Hwang JH, Jeong ST, et al: Effect of muscle activity and botulinum toxin dilution volume on muscle paralysis. Dev Med Child Neurol 2003;45:200-6
27. Haig AJ, Goodmurphy CW, Harris AR, et al: The accuracy of needle placement in lower-limb muscles: A blinded study. Arch Phys Med Rehabil 2003;84: 877-82
28. ChinT, Selber P, Graham HK: Accuracy of intramuscular injection of botulinum toxin A: A comparison between manual needle placement and placement guided by electrical stimulation. Dev Med Child Neurol 2003;45(suppl 96):9